FDA issued a Warning Letter to Jajco, Inc. DBA Anchor Drugs Pharmacy on 8/22/2017 for a previous inspection.
483 Jajco DBA Anchor Drugs Pharmacy Oct 2018

483 Jajco DBA Anchor Drugs Pharmacy Oct 2018

Farhana Khan FDA, Ashar Parikh FDA$119.00 - Available Now

FDA investigators audited the Jajco DBA Anchor Drugs Pharmacy - South San Francisco, CA, United States facility and issued inspectional observations (via FDA 483) on 29 Oct 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Oct 2018
  • Location: South San Francisco, United States
  • FEI: 3012327563
Add To Cart